A recent doctoral study at the Desmond Tutu Tuberculosis Centre at Stellenbosch University (SU), South Africa has shown that hospital-based intervention could help address the tuberculosis hospital reporting gap. The university said there were many children with tuberculosis that didn’t receive the necessary treatment because of challenges with diagnosis and reporting. “In South Africa, thousands […] Continue reading ->
Tuberculosis care is quintessentially colonial, even in 2021. While many countries have been emancipated from their colonizers, the heritage of the colonial mindset, culture and even entire economies is deeply embedded within high burden TB countries in the post-colonial era.   A disease of poverty, TB has historically been terribly neglected. Although the number one infectious […] Continue reading ->
NEW DELHI – Reversing decades of negative messages, the World Health Organisation is once again endorsing the use of X-rays as a TB screening tool  in lower-income countries – this time in conjunction with the use of new artificial intelligence programmes that can read digital x-rays and identify suspected TB cases more accurately.  For community-level […] Continue reading ->
In a decisive act of global solidarity, Norway has offered almost a third of its allocation of COVAX vaccines to poorer countries, according to Dag-Inge Ulstein, Norway’s Minister of International Development. Norway has only fully vaccinated about 5% of its population – 260,000 people – and unlike many other European countries, it has not stockpiled […] Continue reading ->
British-Swedish pharma company AstraZeneca may have included outdated information from their COVID-19 vaccine trial, the US National Institute of Allergy and Infectious Diseases (NIAID) said in a statement released Tuesday.  The NIAID, part of the National Institutes of Health, urged AstraZeneca to work with the US  Data Safety and Monitoring Board (DSMB) to review the […] Continue reading ->
In news that should be reassuring for skeptics, the Oxford/AstraZeneca COVID-19 vaccine was found to be 79% effective in preventing symptomatic COVID-19 and 100% effective against severe disease and hospitalization in results of a late-stage clinical trial, published today by the pharma company. What’s more, analysis of safety results by an independent board found no […] Continue reading ->
Developers of Russia’s Sputnik V vaccine have entered into a partnership with Stelis Biopharma, an India-based drugmaker, to produce 200 million doses of the COVID-19 vaccine. Stelis is now the latest addition to the global production network for Sputnik V.  The Russian Direct Investment Fund (RDIF), the company responsible for marketing the Sputnik vaccine abroad, […] Continue reading ->